How Serum Pharma Advances Green Tea Extract Supply Through Botanical Innovation, Quality Control and Market Applications

Sep 5, 2026



Nanchang, Jiangxi Sep 5, 2026 (Issuewire.com) - As demand for plant-based nutritional ingredients and functional health products continues to expand, manufacturers and distributors are placing greater emphasis on ingredient quality, supply stability and application versatility. Green Tea Extract has become an important ingredient in this evolving market, supported by growing interest in botanical extracts, tea-derived compounds and functional nutrition. Against this backdrop, Jiangxi Serum Pharma Industries Co., Ltd. is strengthening its position as a professional supplier of pharmaceutical and nutritional products by combining botanical ingredient supply, quality management and international market experience.

For nearly a decade, Serum Pharma has focused on exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives and plant extracts. The company reports that its products have reached more than 30 countries across Asia, Africa, South America, the Middle East and Europe. Its international experience provides a foundation for serving customers with diverse regulatory, quality and supply requirements. The company also states that it has obtained multiple certifications, including Chinese GMP and ISO9001 quality certification.

Green Tea Extract as Part of a Broader Botanical Portfolio

Green Tea Extract represents one component of Serum Pharma's broader nutritional ingredient portfolio. The company categorizes its nutritional products into areas including tea extracts, anthocyanidins, fruit powders, other extracts, oil powders, essential oils, proteins, peptides, probiotics and other specialties. This structure enables customers to source multiple types of functional ingredients through a supplier with experience across both nutritional and pharmaceutical product categories.

Within the tea-related segment, Black Tea Extract and L-Theanine From Green Tea complement Green Tea Extract by expanding the range of tea-derived ingredients available for nutritional formulations. These ingredients can serve different formulation strategies depending on the target product, processing requirements and desired ingredient profile.

The company's botanical portfolio also includes Bilberry Extract, Grape Seed Extract and OPC, Ganoderma Lucidum Extract, Goji Berry Extract, Wolfberry Extract and Curcumin Extract. Other plant-based ingredients include Chrysanthemum Powder, Cordyceps Sinensis Extract, Peach Fruit Powder, Orange Powder, Eucalyptus Oil and Elderberry Extract. By maintaining a diversified range of botanical ingredients, Serum Pharma can address the needs of customers developing nutritional supplements, functional foods, beverage formulations and other health-oriented products.

 

Quality Control Becomes Central to Ingredient Supply

For international buyers, the value of a botanical ingredient supplier extends beyond the availability of individual products. Consistency, traceability and supplier reliability are increasingly important considerations when purchasing plant extracts and functional ingredients.

Serum Pharma states that it has established a complete quality assurance system in accordance with China's export supervision requirements for drugs and overseas market demands. Its quality control process covers raw material procurement through finished-product shipment, with orders fulfilled by selected suppliers and inspected by the company's quality assurance department before shipment. According to the company, this approach is designed to support product reliability and traceability.

This quality-oriented approach is particularly relevant to Green Tea Extract, where buyers may require dependable sourcing and consistent specifications for downstream manufacturing. The same supply philosophy can also be applied across the company's wider ingredient portfolio, from botanical extracts and fruit powders to proteins, peptides and specialized functional ingredients.

Expanding Functional Nutrition Through Proteins and Peptides

The growth of functional nutrition is also increasing demand for plant-based proteins and peptide ingredients. Serum Pharma's portfolio includes Pea Protein Peptides, Fava Bean Protein Peptides, Mung Bean Protein Peptides and Fava Bean Peptides, providing customers with multiple plant-derived options for formulation development.

These products complement botanical ingredients by allowing manufacturers to develop more diversified ingredient combinations. Instead of relying on a single category of raw materials, product developers can evaluate tea extracts, fruit-based ingredients, plant proteins and peptides according to the requirements of their individual formulations.

The company's nutritional ingredient portfolio further includes Medium Chain Triglyceride, Flaxseed Oil Powder, Akkermansia Muciniphila, Coenzyme Q10, Ubidecarenone and Ubiquinone Powder. The presence of these products reflects a broader supply strategy focused on functional nutrition and specialty ingredients rather than a narrow emphasis on one botanical category.

'-Nicotinamide Mononucleotide is another specialty ingredient within the supplied portfolio, illustrating the company's approach to serving customers seeking a wider selection of nutritional and functional raw materials.

Connecting Botanical Ingredients With Pharmaceutical Supply

One of Serum Pharma's distinguishing characteristics is its combination of nutritional ingredients with pharmaceutical products and active pharmaceutical ingredients. The company's product structure includes generic medicines, APIs and intermediates, vaccines and biologicals, veterinary drugs and other pharmaceutical categories.

Its pharmaceutical portfolio includes products such as Cefuroxime Sodium Injection, Cefotaxime Sodium Injection, Ampicillin Capsules, Cloxacilin Sodium Injection, Benzylpenicillin Sodium Injection, Amoxicillin Sodium Injection and Oxacilin Sodium Injection. The company also supplies API products including Ampicillin Trihydrate, Dicloxacillin Sodium, Ceftriaxone Sodium and other pharmaceutical raw materials.

Additional products include Amoxicillin Capsules and Diclofenac Sodium. While these pharmaceutical products serve different applications from nutritional ingredients such as Green Tea Extract, their inclusion within the same international supply platform demonstrates Serum Pharma's ability to operate across multiple product categories.

For overseas buyers, this diversified structure can provide a broader sourcing channel for pharmaceutical and nutritional requirements. It also places greater importance on quality management, documentation, supplier selection and logistics coordination across different product categories.

Building an International Supply Network

Serum Pharma's international development is another factor shaping its approach to product supply. According to the company, its products have been exported to more than 30 countries across Asia, Africa, South America, the Middle East and Europe, including markets such as the Philippines, Bangladesh, Laos, Cambodia, Kyrgyzstan, Cameroon, Guinea, Nigeria, Liberia, Mali, Yemen, Türkiye, Chile and Australia. The company also reports established terminal-user relationships in multiple markets.

This international footprint supports a supplier model that emphasizes product quality, competitive pricing and delivery responsiveness. Serum Pharma states that it has developed close cooperative relationships with domestic manufacturers of biological products, vaccines, raw materials, excipients and plant extracts, allowing it to combine resources and complementary capabilities.

For customers sourcing Green Tea Extract and related nutritional ingredients, such a supply network can be important when demand extends beyond a single product or market. Buyers may require several botanical extracts, functional ingredients or pharmaceutical materials within the same sourcing program, making supplier breadth increasingly valuable.

A Broader Approach to Green Tea Extract Supply

The development of the global nutritional ingredient market is creating new expectations for suppliers. Buyers are increasingly evaluating not only product availability but also quality assurance, supply continuity, portfolio breadth and international service capabilities.

Serum Pharma's approach combines these elements through its nutritional ingredient portfolio, pharmaceutical product range, supplier relationships and quality-control system. Green Tea Extract therefore represents more than an individual product within its catalog; it forms part of a broader strategy to provide botanical, nutritional and pharmaceutical ingredients to international customers.

By combining Green Tea Extract with Black Tea Extract, L-Theanine From Green Tea, Bilberry Extract, Grape Seed Extract, Goji Berry Extract, plant proteins, peptides, specialty nutritional ingredients and pharmaceutical products, Serum Pharma is positioned to support customers with diversified sourcing requirements. Its emphasis on quality assurance, competitive pricing and international delivery further reflects the changing expectations of global ingredient buyers.

As demand for botanical and functional ingredients continues to develop, suppliers with diversified portfolios and established international supply capabilities may become increasingly important to manufacturers seeking reliable raw-material partners. Serum Pharma's combination of nutritional ingredients, pharmaceutical products and quality-focused supply management provides a foundation for continued participation in this evolving market.

For more information about Green Tea Extract, botanical ingredients, nutritional products and pharmaceutical products supplied by Jiangxi Serum Pharma Industries Co., Ltd., visit the company's official website:https://www.jxserum.com/

Media Contact

Jiangxi Serum Pharma Industries Co., Ltd.


[email protected]

+86-190-6796 3032

Source :JIANGXI SERUM PHARMA INDUSTRIES CO., LTD.

This article was originally published by IssueWire. Read the original article here.

MORE NEWS
Amid brutal sell-off, what comes next for Google, Amazon and other Big Tech titans?
Oct 30, 2026
Amid brutal sell-off, what comes next for Google, Amazon and other Big Tech titans?

Soaring artificial intelligence revenues have failed to shield Intel, Amazon and Google’s parent company Alphabet from a brutal Wall Street sell-off, as their latest quarterly results deepened investor jitters over mounting capital spending and delayed returns. Intel plunged about 23 per cent in extended trading on Thursday, while Amazon shed 7.3 per cent. Alphabet tumbled 12.6 per cent during the regular session in its worst day on record, dragging the Nasdaq Composite down 1.4 per cent and...

Roblox hands Fave founder Joel Neoh the keys to SEA. His first job isn’t growth, it’s trust
Oct 30, 2026
Roblox hands Fave founder Joel Neoh the keys to SEA. His first job isn’t growth, it’s trust

Joel Neoh has spent two decades selling things to adults: group-buying deals at Groupon, cashback at Fave, DNA kits and supplements at Prenetics. His new job asks him to build a business on a platform where a large slice of the audience still needs a parent’s permission to buy anything. Roblox has appointed the Malaysian […] The post Roblox hands Fave founder Joel Neoh the keys to SEA. His first job isn’t growth, it’s trust appeared first on e27.

North Korea’s hiring scam just cost Binance US$6.3B. SEA’s engineers are on the shortlist
Oct 30, 2026
North Korea’s hiring scam just cost Binance US$6.3B. SEA’s engineers are on the shortlist

For years, Southeast Asia’s crypto regulators have asked exchanges the same set of questions. Where is your licence? Where is your local entity? Where are your cold wallets, and whose name is on them? On October 29, North Korea answered with a question of its own: whose laptop is this? Binance, the world’s largest crypto […] The post North Korea’s hiring scam just cost Binance US$6.3B. SEA’s engineers are on the shortlist appeared first on e27.

German chancellor urges global trade alliance as Germany deepens Indo-Pacific ties
Oct 30, 2026
German chancellor urges global trade alliance as Germany deepens Indo-Pacific ties

German Chancellor Friedrich Merz called for a global political alliance to defend rules-based trade, urging Germany and Indo-Pacific economies to strengthen economic partnerships and diversify supply chains as geopolitical tensions and intensifying U.S.-China competition reshape the global economy. Speaking at the opening of the 19th Asia-Pacific Conference of German Business (APK) in Seoul on Friday, Merz proposed establishing a "global political alliance for rules-based trade" to defend and strengthen the international trading system and coordinate joint action when it comes under threat. “When supply chains become political pawns, when access to key technologies is imperiled or when efforts to secure raw materials become a projection of power rather than of fair partnership, this jeopardizes growth, prosperity and, ultimately, the security,” he said. “Countries that decouple lose security, innovative strength, prosperity and scope for action. We do not wish to withdraw but rather to expand our freedom of action.” Turning to bilateral ties, the chancellor said Germany and Korea

Goldman Sachs eyes Tmap Mobility acquisition by year-end
Oct 30, 2026
Goldman Sachs eyes Tmap Mobility acquisition by year-end

Goldman Sachs is seeking to acquire a controlling stake in Tmap Mobility, operator of Korea’s leading navigation app, from SK Square by the end of this year, seeing an investment opportunity in its lower valuation and vast trove of mobility data as autonomous driving advances, industry sources said Friday. For SK Square, SK Group’s investment arm and the largest shareholder of SK hynix, the sale is part of a broader strategy to focus on artificial intelligence (AI) and semiconductors. The global investment bank is looking to invest between 600 billion won ($450 million) and 800 billion won to secure a 60 to 70 percent stake in Tmap Mobility. It is in talks to buy shares from SK Square, the largest shareholder with a 63.23 percent stake, as well as other financial investors, including Affirma Capital and EastBridge Partners, which each hold 9.83 percent, and KB Kookmin Bank, which owns 6.39 percent. Tmap Mobility traces its roots to a navigation service launched by SK Telecom in 2002. The telecom operator spun off its mobility business into a separate company in December 2020, and Tm

Hanwha Systems wins SAR microsatellite constellation project
Oct 30, 2026
Hanwha Systems wins SAR microsatellite constellation project

Hanwha Systems has won a contract to develop synthetic aperture radar (SAR) satellites for Korea's microsatellite constellation aimed at enhancing national security and disaster response capabilities, data showed Friday. The defense solutions arm of Hanwha Group was selected for the SAR satellite development project commissioned by the state-run Agency for Defense Development (ADD), according to the Public Procurement Service. The microsatellite development project is a joint initiative involving the defense ministry, the Korea AeroSpace Administration (KASA) and the Korea Coast Guard to strengthen surveillance of security threats and natural disasters on the Korean Peninsula and in surrounding waters. SAR satellites can capture images of land and sea regardless of weather conditions or time of day. Operating a constellation of small satellites allows for more frequent monitoring of specific areas and faster intelligence gathering. Hanwha Systems has previously supplied SAR sensors and data links for Korea's military reconnaissance satellites.

LIG D&A faces growing hurdles in global arms export amid bribery scandal
Oct 30, 2026
LIG D&A faces growing hurdles in global arms export amid bribery scandal

LIG Defense & Aerospace's (LIG D&A) overseas expansion plans could be in jeopardy, as an ongoing bribery scandal threatens to disrupt its defense development and production pipeline through a potential two-year government bidding ban. The Seoul Administrative Court will hold a hearing on Thursday to review the company's request to suspend the enforcement of a two-year restriction imposed by the Defense Acquisition Program Administration (DAPA). Last week, the defense authority imposed the penalty on allegations that the firm’s executives offered bribes worth hundreds of millions of won to a DAPA employee during the bidding process for a weapons development project. LIG D&A denied the allegations and has taken legal steps for a temporary suspension of the penalty, which was originally scheduled to take effect on Thursday. The suspension will remain in place until Nov. 20. The potential disruption carries significant implications for the company's business structure. Its government and public institution clients accounted for 64.5 percent, or 2.78 trillion won ($2.07 billion), of LIG D&A

Volkswagen Atlas stands out as family SUV with top-tier child seat safety
Oct 30, 2026
Volkswagen Atlas stands out as family SUV with top-tier child seat safety

Volkswagen’s Atlas is positioning itself as a family-oriented large SUV, combining child seat-friendly design, spacious seating and advanced safety features. The model has earned recognition in the United States for its child seat installation convenience and crash protection, reinforcing its appeal to families with young children. Produced more than 1 million times in North America over the past nine years, the Atlas has established itself as one of Volkswagen’s flagship models in the U.S. market. It was also introduced in Korea last year, offering a spacious six- or seven-seat configuration. One of its key strengths is its ability to accommodate multiple child seats. The seven-seat version can fit three child seats in the second row, while the third row can accommodate two additional seats using seat belts and anchor points. The Atlas was named a Top Finisher in Cars.com's 2026 Best Cars for Car Seats evaluation. It received an A grade in nearly all installation categories, with the second-row booster seat installation receiving a B. Its second-row seats can also tilt forward witho

Kia's Q3 profit jumps 24.3% on hybrid, SUV sales growth
Oct 30, 2026
Kia's Q3 profit jumps 24.3% on hybrid, SUV sales growth

Kia has achieved solid earnings growth in the third quarter, supported by rising sales of hybrids, electric vehicles (EVs) and popular SUV models across major markets, the carmaker said Friday in a regulatory filing. The carmaker said its operating profit between July and September jumped 24.3 percent to 1.82 trillion won ($1.36 billion). Sales also increased 10.2 percent to 31.6 percent during the same period. The automaker's earnings growth was driven by its diversified electrification strategy, as it helped sustain growth despite weakening global auto demand, Kia said. Global vehicle sales rose 7.9 percent to 847,355 vehicles in the third quarter on balanced sales growth of its hybrids, EVs and SUV models. Kia's SUV lineup, including the Sportage, Carnival and newly introduced Telluride Hybrid, helped drive sales in the United States, where retail sales rose 7.8 percent to approximately 234,000 units. The automaker's U.S. market share reached a quarterly record of 5.8 percent. Hybrid sales in the U.S. surged 118 percent to 69,000 vehicles, significantly outpacing the market's 27 percen

Seoul AI Foundation, robot agency team up on physical AI services
Oct 30, 2026
Seoul AI Foundation, robot agency team up on physical AI services

The Seoul AI Foundation has signed an agreement with the state-run Korea Institute for Robot Industry Advancement (KIRIA) to develop joint projects that combine artificial intelligence and robotics to address the city’s needs, the foundation said Friday. The memorandum of understanding was signed Oct. 7 at Smart Life Week 2026, an artificial intelligence (AI) and smart city exhibition hosted by the Seoul Metropolitan Government at Coex in southern Seoul. Seoul AI Foundation Chairman Kim Man-gi and KIRIA President Cho Young-hoon attended the signing. The Seoul AI Foundation is a city-funded body that develops AI policies and services for Seoul. KIRIA operates under the industry ministry to promote the country’s robot industry. The agreement comes as AI expands into what is known as physical AI, in which AI systems control robots and other machines that operate in the real world. Under the agreement, the two organizations will share information and experts on AI and robot policy, technology and industry. They will also identify and carry out joint projects and cooperate on exhibitions,

Hyundai Motor advances $6.3 bil. AI hub in Saemangeum
Oct 30, 2026
Hyundai Motor advances $6.3 bil. AI hub in Saemangeum

Hyundai Motor Group said Friday it will set up two special purpose companies next month to build and operate an artificial intelligence (AI) data center in Saemangeum — a massive reclaimed coastal zone in southwestern Korea — accelerating its 9 trillion won ($6.3 billion) plan to turn the area into an advanced tech hub. Situated in North Jeolla Province roughly 200 kilometers south of Seoul, Saemangeum is a vast, government-backed development area created by damming tidal flats to claim new land from the sea. Long slated for economic transformation, the coastal territory is being developed as a strategic enclave for high-tech industry, green energy and tourism. Five affiliates — Hyundai Motor, Kia, Hyundai Mobis, Hyundai Engineering & Construction and Hyundai AutoEver — have made final decisions to invest in the data center, the group said. Hyundai AutoEver, the group’s information technology and software affiliate, approved its participation through a board resolution. One of the new companies will build the hyperscale data center and its infrastructure. The other will buy hi

Samsung, gas safety agency join forces to protect chip operations
Oct 30, 2026
Samsung, gas safety agency join forces to protect chip operations

Samsung Electronics and Korea Gas Safety Corp. have agreed to tighten safety controls at semiconductor facilities in Korea and overseas, seeking to prevent gas-related accidents and protect production continuity as the country's chip industry expands. The two organizations signed a memorandum of understanding Thursday at Samsung's Pyeongtaek campus, focusing on strengthening gas safety infrastructure at facilities designated as nationally critical semiconductor sites. The agreement calls for closer technical cooperation to stabilize newly built facilities, including inspections of pipeline integrity and verification that gas installations meet safety requirements. Under the partnership, the organizations will conduct regular inspections of facilities and pipelines at new sites, provide training to develop specialized safety personnel and share technical information on gas safety. They also plan to jointly identify regulatory obstacles affecting semiconductor operations and explore ways to improve relevant rules. Another key element involves conducting joint special inspections of gas faci

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

About Us

Always dynamic, always updated, The Witness Daily ensures minute-by-minute update to the most pressing issues, curated specifically to cater to critical newsreaders of our time.

Copyright © 2015 - 2026 Redshift Daily. All Rights Reserved.